Wednesday, August 17, 2011

BROOKS LAB IPO GETS TEPID RESPONSE.

The IPO which closes tomorrow has received subscription to the extent of 26% only. The issue has been aggressively priced in the price band of Rs 90-100.

FIRST CHOICE IPO ADVISES THE INVESTORS TO STAY AWAY FROM THE ISSUE.

No comments:

Post a Comment